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Abstract The second messenger role of ATP in insulin secretion
was investigated in living INS-1 insulinoma cells. ATP-
dependent luminescence was monitored in cells expressing high
levels of firefly luciferase under the control of the tetracycline-
dependent transactivator. The calibration of luminescence in
permeabilized cells yielded similar ATP levels as those obtained
in cell extracts with a conventional ATP assay. Stimulation of
insulin secretion by glucose or methyl-succinate was correlated
with rises of cellular ATP in simultaneous measurements. ATP
generation was decreased by inhibition of the ADP-ATP
translocase. This approach demonstrates the feasibility of
defining the dynamic relationship between ATP and other
parameters involved in metabolism-secretion coupling.
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1. Introduction
The measurement of cellular ATP levels in living cells is
crucial for assessing the metabolic state. In the pancreatic L-
cell glucose undergoes a complex metabolic cascade leading to
adequate insulin secretion. A rise in cytosolic ATP concentra-
tion is a key event in the closure of KATP channels and the
following membrane depolarization [1,2]. This results in the
opening of voltage-dependent L-type Ca2 channels and the
subsequent increase in cytosolic Ca2 is the main trigger for
exocytosis [3]. The ATP/ADP ration has been reported to
oscillate in synchrony with cytosolic [Ca2] in glucose stimu-
lated L-cells [4]. Furthermore, ATP is also required in the
distal events governing exocytosis [3].
Determinations of cellular ATP levels are usually per-
formed in cell extracts but have also been assessed in cells
injected with the ATP-dependent luminescent protein ¢re£y
luciferase [5,6]. In pancreatic L-cells the measurement of cy-
tosolic ATP levels in cell extracts is biased by the high ATP
content of the insulin-containing secretory granules [7]. The
present study describes the establishment of an insulin secret-
ing cell line (INS-1) expressing cytosolic luciferase (EC
1.13.12.7) derived from the ¢re£y Photinus pyralis [8]. Using
these cells in a photon detection apparatus we have monitored
cellular ATP changes simultaneously with the stimulation of
insulin secretion by glucose and the mitochondrial substrate
methyl-succinate.
2. Materials and methods
2.1. Materials
Luciferin and rabbit anti-luciferase immunoglobulin were obtained
from Promega (Madison, WI, USA); bovine serum albumin, doxycy-
cline, methyl-succinate, ¢re£y lantern extract, FCCP and atractyloside
from Sigma (St. Louis, MO, USA); anti-insulin antibody from (Lin-
co, St Charles, MO, USA); G418 and hygromycin from Calbiochem
(San Diego, CA, USA).
2.2. Cell culture and establishment of luciferase expressing cells
INS-1 cells were cultured in RPMI1640 medium as previously de-
scribed [9]. The inducible luciferase expressing INS-1 sub-line was
established by two-stage transfection using the Ca2-phosphate-
DNA co-precipitation method [10]. The ¢rst-step stable cell line ex-
pressing the reverse tetracycline-dependent transactivator was gener-
ated as previously reported [11] by transfection of INS-1 cells with
plasmid PUHG17-1 [12] plus RSVNeo. Resistant colonies were iso-
lated with cloning rings after selection with 350 Wg/ml G418 for
3 weeks. Clones positive for expression of reverse tetracycline-depend-
ent transactivator were screened out by transient transfection with
plasmid PUHC13-3 encoding the luciferase gene driven by a minimal
cytomegalovirus promoter complemented with multiple copies of the
tetracycline operator DNA element [12,11]. Positive clones that ex-
hibited very high tetracycline-inducible luciferase activity and barely
detectable basal luciferase activity were chosen for the next round of
stable transfection with plasmid PUHC13-3 plus TK-hygromycin (a
kind gift from Dr. Nancy Quintrell, University of California, San
Francisco, CA). After 3 weeks selection with 200 Wg/ml hygromycin,
resistant colonies were cloned and screened for high luciferase activity
after 16 h of cell culture with 1 Wg/ml doxycycline. The clone used for
the current study (INS-r3-LUC7) exhibited several thousand-fold tet-
racycline-inducible luciferase activities. The cells were maintained in
long-term culture with G418 (150 Wg/ml) and hygromycin (100 Wg/ml).
2.3. Immuno£uorescence
INS-1 cells were grown on polyornithine treated glass coverslips for
3 days prior to overnight treatment with 1 Wg/ml doxycycline to in-
duce luciferase expression. The cells were then washed, ¢xed in 4%
paraformaldehyde, permeabilized with 0.1% Triton X-100 in phos-
phate-bu¡ered saline, 1% BSA (PBS-BSA). The preparation was
then blocked with PBS-BSA before staining using rabbit anti-lucifer-
ase immunoglobulin followed by rhodamine-labelled goat anti-rabbit
IgG as second antibody. Cells were viewed using a Zeiss laserscan
confocal 410 microscope.
2.4. ATP measurements in cell extracts
According to the protocol of Stanley and Williams [13], cells were
stimulated for 10 min at 37‡C and scraped into 1 ml 0.4 N HClO4 to
terminate the reaction. Following neutralization with 2 N K2CO3, cell
extracts were incubated with a luciferin-luciferase mixture in arsenate
bu¡er (0.1 M Na2HAsO4W7H2O pH 7.4, 20 mM MgSO4W7H2O) and
the resultant luminescence measured.
2.5. Permeabilization of cells
Attached cells were grown on coverslips coated with an extracellu-
lar matrix which was generated by con£uent A431 cells detached with
1% Triton X-100 [14]. After a 4^5 day culture period, cells were ¢rst
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washed with a Ca2-free HEPES balanced Krebs-Ringer bicarbonate
bu¡er (KRBH) prior to permeabilization with Staphylococcus aureus
K-toxin [15,16] (1 Wg/coverslip, i.e. per 4^5U105 cells) at 37‡C for
8 min in 100 Wl of an intracellular-type bu¡er as described elsewhere
[16].
2.6. Measurements of luminescence and insulin secretion
Luciferase expressing cells were seeded on 13 mm diameter cover-
slips 4^5 days prior to analysis and maintained in the same medium as
above except for the omission of G418 and hygromycin. For intact
cell experiments, cells were seeded on plastic polyornithine treated
coverslips at a density of 4U105 cells/ml. For permeabilized cell ex-
periments, cells were seeded at 2U105 cells/ml on A431 extracellular
matrix coated coverslips as described above. Prior to luminescence
measurements, cells were maintained in glucose- and glutamine-free
RPMI1640 plus 10 mM HEPES for 2^5 h at 37‡C. Luminescence was
measured by placing the coverslip in a 0.5 ml termostatted chamber at
37‡C approximately 5 mm from the photon detector. We used a
photomultiplier apparatus (EMI 9789, Thorn-EMI, England) and
data were collected every second on a computer-photon counting
board (EMI C660). The cells were perifused at a rate of 1 ml/min
and, where indicated, 1 min fractions of the e¥uent were collected for
insulin measurements. Intact cells were perifused with KRBH (135
mM NaCl, 3.6 mM KCl, 10 mM HEPES, pH 7.4, 2 mM NaHCO3,
0.5 mM NaH2PO4, 0.5 mM MgCl2, 1.5 mM CaCl2, and 2.8 mM
glucose) plus 10 WM beetle luciferin where mentioned. Permeabilized
cells were perifused with an intracellular-type bu¡er with di¡erent
ATP concentrations (1^10 mM) and a free Ca2 concentration of
about 500 nM (140 mM KCl, 5 mM NaCl, 7 mM MgSO4, 20 mM
HEPES, pH 7.0, 10.2 mM EGTA, 6.67 mM CaCl2). For insulin
secretion experiments, 0.1% of bovine serum albumin was added to
bu¡ers as carrier and insulin was measured by radioimmunoassay
using rat insulin as standard [16].
3. Results and discussion
3.1. Expression of luciferase in INS-1 cells
Expression and cellular localization of luciferase in INS-1
cells was examined by immuno£uorescence. In untransfected
cells only the background due to non-speci¢c binding of the
antibody can be seen (Fig. 1A). In INS-1 cells expressing
tetracycline-inducible luciferase (INS-r3-LUC7) the immuno-
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Fig. 1. Expression and cellular localization of luciferase in INS-1 cells. Immuno£uorescence using anti-luciferase antibody was performed in
control untransfected INS-1 cells (A) and cells expressing tetracycline inducible luciferase (B) after an overnight treatment with 1 Wg/ml doxycy-
cline. C: Doxycycline induced cells were placed in a termostatted chamber for photon collection. After a few minutes of perifusion, luciferin
(10 WM) was added to the KRBH bu¡er. The mitochondrial uncoupler FCCP (1 WM) was added for 5 min to the cells expressing luciferase.
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£uorescence revealed a homogeneous cytosolic expression of
the protein (Fig. 1B). The luciferase expression is under the
control of a reverse tetracycline-dependent transactivator and
was therefore induced by the tetracycline derivative doxycy-
cline (1 Wg/ml of culture medium for 20^60 h). This permits a
very high expression of the transfected gene (around 1000-
fold) at the time of the experiment [17,11].
Changes in luminescence were monitored on attached cells
maintained at 37‡C. In non-transfected control cells only the
background emission (approximately 30 photons/s) was meas-
ured even in the presence of 10 WM luciferin (Fig. 1C). In
luciferase expressing cells the addition of 10 WM luciferin
raised the baseline to a plateau of approximately 5000 pho-
tons/s. Impairment of mitochondrial function by the uncou-
pling protonophore FCCP (1 WM) rapidly decreased the sig-
nal. This latter e¡ect was not fully reversible, probably
indicative of some mitochondrial damage. We have previously
observed morphological changes in INS-1 cell mitochondria
treated for 30 min with FCCP [18].
3.2. Cellular ATP calibration in permeabilized cells
Luciferase expressing cells were permeabilized with K-toxin
and perifused with an intracellular-type bu¡er containing dif-
ferent ATP concentrations ranging from 1 to 10 mM. In a
typical experiment, perifusion ¢rst of 10 mM then of 5 mM
ATP resulted in a plateau of photon emission of approxi-
mately 17 500/s and 9500/s respectively (Fig. 2A). The transi-
ent peak above the plateau just after the addition of luciferin
is likely to re£ect the transition to a new equilibrium binding
state of luciferase with its two substrates [19]. There was a
linear relationship between ATP perfused into permeabilized
cells and photon emission from 1 to 10 mM ATP (Fig. 2B).
The constants for the linear regression, y = ax+b, were
a = 1600 and b = 3209, r = 0.997 and P = 0.0031.
3.3. Generation of ATP and insulin secretion
After the doxycycline treatment period for induction of
luciferase expression, cells were placed in the termostatted
chamber, which permits photon detection and collection of
the e¥uent for insulin measurements. The water volume of
INS-1 cells is assumed to be approximately 1 Wl per 106 cells,
a value established for RINm5F cells which are derived from
the same rat insulinoma [20]. Using this value and the cali-
bration described above the basal ATP level was 7.9 mM
(mean photons/s at basal for 43 traces: 15 845 þ 1577). This
value falls into the same range as the ATP concentration
measured in a luminometer on cell extracts from non-stimu-
lated cells (6.6 mM or 52.4 þ 2.8 nmol/mg protein). When cells
were stimulated for 10 min with 12.8 mM glucose the ATP
concentration in cell extracts was increased to 63.6 þ 3.0 nmol/
mg protein (+21%, P6 0.05, n = 5). When monitored by pho-
ton emission glucose (12.8 mM) rapidly raised the ATP signal
with a plateau around +16% above baseline (Fig. 3A) (mean
of +18 þ 2%, n = 11 from ¢ve experiments). As measured si-
multaneously, glucose stimulated insulin secretion correlated
well with ATP generation but the onset lagged at least 30 s
behind that of the ATP signal (Fig. 3B). Methyl-succinate is a
precursor of the tricarboxylic acid cycle intermediate succinate
and it has been shown to be an insulin secretagogue in pan-
creatic islets [21] and INS-1 cells [16]. The addition of this
mitochondrial substrate (5 mM methyl-succinate) to luciferase
expressing cells increased the cellular ATP by +38% measured
as luminescence (Fig. 3C) (mean of +40 þ 3%, n = 13 from
seven experiments). Insulin secreted from the same cell prep-
aration was stimulated 5-fold above baseline (Fig. 3D). In this
case the two parameters increased almost simultaneously after
a 1 min lag. This lag probably re£ects deesteri¢cation and
transport into the mitochondrial matrix of succinate.
3.4. Inhibition of mitochondrial ATP transport
Atractyloside was used to block the mitochondrial ADP-
ATP translocase which transports ADP into the matrix in
exchange for ATP [22,23]. The presence of 10 WM atractylo-
side markedly attenuated the cytosolic increase in ATP con-
centration induced by methyl-succinate (Fig. 4A). It should be
noted that the inhibitor had no e¡ect on basal luminescence
(see Fig. 4A ¢rst 5 min of pretreatment) nor on luciferase
activity as assessed directly in cell lysates up to 100 WM
(data not shown). When atractyloside was added 5 min after
the beginning of stimulation with methyl-succinate, the signal
was reduced only partially (Fig. 4B). After the removal of the
inhibitor, and the continuous stimulation with methyl-succi-
nate, the cytosolic ATP levels rapidly rose again. The dimin-
ished e⁄cacy of atractyloside in the second compared to the
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Fig. 2. Cellular ATP calibration in permeabilized cells. Luciferase
expression was induced by doxycycline treatment before permeabili-
zation with K-toxin and perifusion with an intracellular-type bu¡er
containing di¡erent ATP concentrations ranging from 1 to 10 mM.
A: Typical experiment of luminescence monitoring when cells were
perifused ¢rst with 10 mM then with 5 mM ATP in the presence of
10 WM luciferin. B: Linear regression analysis for the correlation be-
tween ATP concentration and luciferin-luciferase-dependent lumines-
cence.
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¢rst protocol may be explained by the accumulation of ADP
in the cytosol favoring the production of ATP+AMP by ad-
enylate kinase [24].
The present report shows that cells expressing a high level
of luciferase can be used to monitor cytoplasmic ATP changes
in living cells. This approach permitted the establishment of
the dynamic correlation between ATP levels and insulin secre-
tion in nutrient stimulated cells. Such luciferase expressing cell
lines will be a useful tool for the further elucidation of the role
of ATP in metabolism-secretion coupling in the pancreatic L-
cell. In this context, it will also become necessary to target
luciferase to the mitochondria and other cellular compart-
ments.
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Fig. 3. Nutrient stimulated generation of ATP and insulin secretion. After the doxycycline treatment period for induction of luciferase expres-
sion, cells were placed in the termostatted chamber, which permits photon detection and collection of the e¥uent for insulin measurements. A^
B: After baseline perifusion at 2.8 mM glucose, cells were stimulated for 5 min with 12.8 mM glucose and the e¡ects on cellular ATP (A) and
insulin secretion (B) were monitored on the same cell preparation. C^D: The same protocol was used for stimulation with 5 mM methyl-succi-
nate.
6
Fig. 4. E¡ect of inhibition of mitochondrial ATP transport on ATP
generation. Atractyloside (10 WM) was used to block the mitochon-
drial ADP-ATP translocase. After induction of luciferase expression
by doxycycline treatment, cells were placed in the termostatted
chamber to monitor luminescence in the presence of 10 WM lucifer-
in. A: E¡ect of atractyloside added 5 min prior to methyl-succinate
(5 mM) stimulation. B: E¡ect of atractyloside added for 5 min dur-
ing the continuous stimulation by 5 mM methyl-succinate.
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